Namaste Announces Medical Cannabis Supply Agreement with Tetra Natural Health, to Boost RX Princeps During Cannmart

Namaste Announces Medical Cannabis Supply Agreement with Tetra Natural Health, to Sell RX Princeps Through Cannmart

Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is very happy to announce that the Company has signed a Supply Agreement (the “Supply Agreement”) for the sale and supply of RX Princeps the medicinal marijuana brand of Tetra Natural Health, a division of Tetra Bio-Pharma  (“Tetra Bio-Pharma”)(TSXV: TBP)(OTCQB: TBPMF), whereby Namaste will purchase RX Princeps  from Tetra Natural Health    that is sold via Namaste’s wholly owned subsidiary and Access to Cannabis for Medical Purposes (“ACMPR”) medical cannabis “sales-only” facility, Cannmart Inc. (“Cannmart”). In anticipation of receiving Cannmart’s sales permit, the Company is focused on procuring cannabis from strategic partners to provide through its platform.    

Tetra Bio-Pharma is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their health care providers. In anticipation of receiving its sales permit, Namaste is now focused on ramping up inventory buying of a carefully curated selection of high quality medical cannabis products that will bring value to its patients.

Rx Princeps&commerce; is a unique blend of 3 strains of medical cannabis. Its production has been standardized in order to ensure a lot-to-lot consistent composition in its active ingredients (THC and CBD).

The Supply agreement further supports Namaste’s initiative to provide Cannmart’s patients with the highest quality medical cannabis flower and oil available in the Canadian market. The Company will leverage its technologies including its recent acquisition of leading AI and machine-learning provider Findify AB Inc. (“Findify”) to focus on providing a personalized experience for each patient using machine-learning algorithms. Patient care, retention and selection are core components of Namaste’s strategy to set itself apart from the online retail of medical cannabis. The Company believes it will develop into Canada’s largest platform of medical cannabis patients and in offering an unbelievable patient experience.

Management Commentary

Guy Chamberland , CEO of Tetra Bio-Pharma comments      “We’re thrilled to have signed this partnership deal with Namaste who function as an E-Commerce Medicinal Cannabis supplier with  32 sites in 20 countries, providing substantial exposure forTetra Natural Health’s RX Princeps brand of medicinal marijuana.   We believe this is the making of a solid partnership with Tetra Natural Health’s capacity to produce an excellent product combined with Namaste’s far reaching sales and distribution network.”

Sean Dollinger , President and CEO of Namaste remarks; “We are very pleased to be bringing on a strong supply partner like Tetra Bio-Pharma. RX Princeps is a unique pharma-based product that we feel will be very beneficial for our patients. We’ve got a unique opportunity to develop an exciting platform that will cater specifically to a patients’ needs. We plan on being quite selective in choosing which licensed producers that we will work with to ensure that our patients receive only the best quality medical cannabis available. We plan on providing a single source for all things cannabis and Cannmart and NamasteMD are key components of that strategy together with securing the highest quality cannabis for our patients. We’d like to take the chance to thank Tetra Bio-Pharma management team for their support and look forward to a growing future together.”

The Company has many subsidiaries including Tetra Bio-Pharma participated in the creation of Bio Pharmaceuticals and Tetra Natural Health   focused on Natural Health Products that are Cannabis based and comprise other medicinal plant based components.

Tetra Bio-Pharma relies on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and security data needed for inclusion into the present Bio-Pharma    sector by regulators, doctors and insurance companies.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the world and operates over 30 websites under various brands. Namaste has developed innovative technology platforms such as NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and plans  on building Canada’s largest database of medical cannabis patients. The provider’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” permit, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies that will provide value to the Company and to its shareholders and to the broader cannabis industry.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Email: info@namastetechnologies.com

Further information on the Company and its products can be accessed via the links below:

NamasteTechnologies.com

NamasteMD.com

NamasteVapes.ca

Everyonedoesit.ca

More details at: www.tetrabiopharma.com

FORWARD LOOKING INFORMATION This press release includes forward-looking information based on current expectations. These statements shouldn’t be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no duty to update or revise forward looking information to reflect new events or circumstances unless required by law. Even though the Company believes that the assumptions and expectations on which the forward-looking statements are based are reasonable, undue reliance shouldn’t be set on the forward-looking statements because the Company can give no assurance that they will prove to be right. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of the press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents that may be seen under the Company’s profile on www.sedar.com. The CSE has neither reviewed nor approved the contents of the press

SOURCE Namaste Technologies Inc..

View original content: http://www.newswire.ca/en/releases/archive/May2018/17/c8203.html

Tetra Bio-Pharma Inc., Robert (Bob) Béchard, Vice President, Finance & Business Development, bob@tetrabiopharma.com, -LRB-514-RRB- 817-2514Copyright CNW Group 2018

Released at Thu, 17 May 2018 12:35:29 +0000

Posted in: News

Comments are closed.